Scientists use 'Glowing' scans to watch cancer drug hunt tumors
NCT ID NCT07440212
Summary
This study aims to see how well a new drug called ivonescimab (AK112) travels to and stays in the tumors of people with esophageal cancer. Researchers will use a special PET scan to track a tiny radioactive version of the drug in about 50 patients. The goal is to better understand how the drug behaves in the body to help guide future treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGUS CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Daping Hospital, Army Medical University
Chongqing, Chongqing Municipality, 400010, China
Conditions
Explore the condition pages connected to this study.